X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
surgery (42) 42
index medicus (33) 33
pancreatic cancer (25) 25
gastroenterology & hepatology (24) 24
male (19) 19
female (18) 18
cancer (17) 17
middle aged (17) 17
pancreas (16) 16
abridged index medicus (15) 15
aged (15) 15
pancreatic neoplasms - surgery (15) 15
pancreatic neoplasms - pathology (13) 13
research (13) 13
ductal adenocarcinoma (12) 12
adenocarcinoma (11) 11
ongoing clinical trials (11) 11
adult (9) 9
clinical trials (9) 9
pancreatic neoplasms - genetics (9) 9
pancreaticoduodenectomy (9) 9
prognosis (9) 9
diagnosis (8) 8
resection (8) 8
risk-factors (8) 8
tumors (8) 8
chemotherapy (7) 7
management (7) 7
medicine, general & internal (7) 7
metastasis (7) 7
mortality (7) 7
oncology (7) 7
pancreatectomy - methods (7) 7
pancreatic neoplasms - diagnosis (7) 7
treatment outcome (7) 7
acute disease (6) 6
carcinoma, pancreatic ductal - pathology (6) 6
care and treatment (6) 6
endoscopy (6) 6
gastroenterology and hepatology (6) 6
industry (6) 6
medical research (6) 6
pancreatic neoplasms - drug therapy (6) 6
pancreatic neoplasms - mortality (6) 6
survival (6) 6
aged, 80 and over (5) 5
authorship (5) 5
biomarkers (5) 5
carcinoma (5) 5
carcinoma, pancreatic ductal - genetics (5) 5
carcinoma, pancreatic ductal - surgery (5) 5
clinical trials as topic - standards (5) 5
conflict of interest (5) 5
contract services (5) 5
distal pancreatectomy (5) 5
drug industry (5) 5
ethics, professional (5) 5
gemcitabine (5) 5
genetic aspects (5) 5
guidelines (5) 5
health aspects (5) 5
metaanalysis (5) 5
neoplasm staging (5) 5
pancreatectomy (5) 5
pancreatectomy - adverse effects (5) 5
pancreatitis (5) 5
patient selection (5) 5
publishing - standards (5) 5
research support as topic (5) 5
review (5) 5
risk factors (5) 5
studies (5) 5
analysis (4) 4
animals (4) 4
clinical medicine (4) 4
cysts (4) 4
diagnosis, differential (4) 4
endoscopic retrograde cholangiopancreatography (4) 4
fistula (4) 4
folinic acid (4) 4
genetics (4) 4
international study-group (4) 4
klinisk medicin (4) 4
laparoscopy (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
medicine & public health (4) 4
metastases (4) 4
mice (4) 4
morbidity (4) 4
mutations (4) 4
neoplasm invasiveness (4) 4
oncology, experimental (4) 4
original paper (4) 4
pancreas - pathology (4) 4
pancreatic neoplasms - diagnostic imaging (4) 4
pancreatitis - complications (4) 4
polymorphism, single nucleotide (4) 4
postoperative complications (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2016, Volume 161, Issue 3, pp. 584 - 591
Journal Article
Surgery, ISSN 0039-6060, 2014, Volume 155, Issue 6, pp. 977 - 988
Journal Article
Surgery, ISSN 0039-6060, 2014, Volume 156, Issue 3, pp. 591 - 600
Journal Article
Surgery, ISSN 0039-6060, 2014, Volume 156, Issue 1, pp. 1 - 14
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2016, Volume 161, Issue 5, pp. 1221 - 1234
Journal Article
Surgery, ISSN 0039-6060, 2014, Volume 155, Issue 5, pp. 887 - 892
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2016, Volume 161, Issue 2, pp. 365 - 372
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article